T1	AdverseReaction 65 91	worsening renal impairment
T2	AdverseReaction 105 124	acute renal failure
T3	AdverseReaction 129 145	Fanconi syndrome
T4	AdverseReaction 1327 1360	Decreases in bone mineral density
T5	AdverseReaction 1509 1523;1537 1548	Redistribution of body fat
T6	AdverseReaction 1524 1548	accumulation of body fat
T7	AdverseReaction 1620 1650	Immune reconstitution syndrome
T8	AdverseReaction 1784 1799	Lactic acidosis
T9	AdverseReaction 1811 1823	hepatomegaly
T10	Severity 1804 1810	severe
T11	AdverseReaction 1829 1838	steatosis
T12	AdverseReaction 1850 1855	fatal
T13	AdverseReaction 3245 3273	exacerbations of hepatitis B
T14	AdverseReaction 3295 3315	liver decompensation
T15	AdverseReaction 3320 3333	liver failure
T16	AdverseReaction 3651 3667	Renal impairment
T17	AdverseReaction 3688 3707	acute renal failure
T18	AdverseReaction 3712 3728	Fanconi syndrome
T19	AdverseReaction 3730 3750	renal tubular injury
T20	AdverseReaction 3763 3779	hypophosphatemia
T21	AdverseReaction 4165 4187	renal adverse reaction
T22	AdverseReaction 4404 4438	proximal renal tubular dysfunction
T23	AdverseReaction 4937 4971	proximal renal tubular dysfunction
T30	AdverseReaction 6386 6415	increases in serum creatinine
T31	Severity 6379 6385	modest
T32	AdverseReaction 6427 6469	declines in estimated creatinine clearance
T33	Severity 6420 6426	modest
T34	AdverseReaction 8770 8803	decreases in bone mineral density
T35	AdverseReaction 9727 9739	osteomalacia
T36	AdverseReaction 9756 9782	proximal renal tubulopathy
T37	AdverseReaction 9798 9807	bone pain
T38	AdverseReaction 9811 9830	pain in extremities
T39	AdverseReaction 9859 9868	fractures
T40	Factor 9841 9844	may
T41	AdverseReaction 9969 9980	Arthralgias
T42	AdverseReaction 9985 9996	muscle pain
T43	AdverseReaction 10000 10008;9985 9991	weakness muscle
T44	AdverseReaction 10045 10071	proximal renal tubulopathy
T45	AdverseReaction 10401 10415;10429 10440	Redistribution of body fat
T46	AdverseReaction 10416 10440	accumulation of body fat
T47	AdverseReaction 10451 10466	central obesity
T48	AdverseReaction 10468 10497	dorsocervical fat enlargement
T49	AdverseReaction 10499 10511	buffalo hump
T50	AdverseReaction 10432 10440;10514 10532	body fat peripheral wasting
T51	AdverseReaction 10534 10548	facial wasting
T52	AdverseReaction 10550 10568	breast enlargement
T53	AdverseReaction 10575 10596	cushingoid appearance
T54	AdverseReaction 10838 10868	Immune reconstitution syndrome
T55	AdverseReaction 11124 11157	residual opportunistic infections
T56	AdverseReaction 11167 11197	Mycobacterium avium  infection
T57	AdverseReaction 11199 11214	cytomegalovirus
T58	AdverseReaction 11216 11249	Pneumocystis jirovecii  pneumonia
T59	AdverseReaction 11251 11254	PCP
T60	AdverseReaction 11260 11272	tuberculosis
T61	AdverseReaction 11335 11355	Autoimmune disorders
T62	AdverseReaction 11365 11380	Graves' disease
T63	AdverseReaction 11382 11394	polymyositis
T64	AdverseReaction 11400 11423	Guillain-Barre syndrome
T66	Factor 93 96	Can
T67	Severity 3756 3762	severe
T24	Factor 6369 6372	may
T25	AdverseReaction 8814 8865	increases in biochemical markers of bone metabolism
T26	AdverseReaction 8878 8901	increased bone turnover
T27	Factor 11072 11075	may
T28	AdverseReaction 8770 8782;8805 8808	decreases in BMD
T29	AdverseReaction 52 61;75 91	New onset renal impairment
T65	AdverseReaction 1327 1339;1362 1365	Decreases in BMD
E1	AdverseReaction:T1
E2	AdverseReaction:T2 Hypothetical:E66
E3	AdverseReaction:T3 Hypothetical:E66
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9 Effect:E10
E10	Severity:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20 Effect:E67
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E30	AdverseReaction:T30 Effect:E31 Hypothetical:E24
E31	Severity:T31
E32	AdverseReaction:T32 Effect:E33
E33	Severity:T33
E34	AdverseReaction:T34
E35	AdverseReaction:T35
E36	AdverseReaction:T36
E37	AdverseReaction:T37
E38	AdverseReaction:T38
E39	AdverseReaction:T39 Hypothetical:E40
E40	Factor:T40
E41	AdverseReaction:T41
E42	AdverseReaction:T42
E43	AdverseReaction:T43
E44	AdverseReaction:T44
E45	AdverseReaction:T45
E46	AdverseReaction:T46
E47	AdverseReaction:T47
E48	AdverseReaction:T48
E49	AdverseReaction:T49
E50	AdverseReaction:T50
E51	AdverseReaction:T51
E52	AdverseReaction:T52
E53	AdverseReaction:T53
E54	AdverseReaction:T54
E55	AdverseReaction:T55 Hypothetical:E27
E56	AdverseReaction:T56 Hypothetical:E27
E57	AdverseReaction:T57 Hypothetical:E27
E58	AdverseReaction:T58 Hypothetical:E27
E59	AdverseReaction:T59 Hypothetical:E27
E60	AdverseReaction:T60 Hypothetical:E27
E61	AdverseReaction:T61
E62	AdverseReaction:T62
E63	AdverseReaction:T63
E64	AdverseReaction:T64
E66	Factor:T66
E67	Severity:T67
E24	Factor:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	Factor:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29
E65	AdverseReaction:T65
A1	CUI E1 C1565489
A2	UMLS-Preferred-Name E1 Renal Insufficiency
A3	MEDDRA-PT E1 Renal impairment
A4	MEDDRA-PT-ID E1 10062237
A5	CUI E2 C0022660
A6	UMLS-Preferred-Name E2 Kidney Failure, Acute
A7	MEDDRA-PT E2 Acute kidney injury
A8	MEDDRA-PT-ID E2 10069339
A9	LLT E2 Acute renal failure
A10	LLT-ID E2 10001041
A11	CUI E3 C0015624
A12	UMLS-Preferred-Name E3 Fanconi Syndrome
A13	MEDDRA-PT E3 Fanconi syndrome
A14	MEDDRA-PT-ID E3 10016219
A15	CUI E4 C0877225
A16	UMLS-Preferred-Name E4 Bone density decreased
A17	MEDDRA-PT E4 Bone density decreased
A18	MEDDRA-PT-ID E4 10049470
A19	CUI E5 C0856151
A20	UMLS-Preferred-Name E5 Fat redistribution
A21	MEDDRA-PT E5 Fat redistribution
A22	MEDDRA-PT-ID E5 10048474
A23	CUI E6 C1096393
A24	UMLS-Preferred-Name E6 Body fat disorder
A25	MEDDRA-PT E6 Body fat disorder
A26	MEDDRA-PT-ID E6 10055164
A27	CUI E7 C1096197
A28	UMLS-Preferred-Name E7 Immune reconstitution syndrome
A29	MEDDRA-PT E7 Immune reconstitution inflammatory syndrome
A30	MEDDRA-PT-ID E7 10065042
A31	LLT E7 Immune reconstitution syndrome
A32	LLT-ID E7 10054014
A33	CUI E8 C0001125
A34	UMLS-Preferred-Name E8 Acidosis, Lactic
A35	MEDDRA-PT E8 Lactic acidosis
A36	MEDDRA-PT-ID E8 10023676
A37	CUI E9 C0019209
A38	UMLS-Preferred-Name E9 Hepatomegaly
A39	MEDDRA-PT E9 Hepatomegaly
A40	MEDDRA-PT-ID E9 10019842
A41	CUI E11 C2711227
A42	UMLS-Preferred-Name E11 Steatohepatitis
A43	MEDDRA-PT E11 Hepatic steatosis
A44	MEDDRA-PT-ID E11 10019708
A45	CUI E12 C1306577
A46	UMLS-Preferred-Name E12 Death (finding)
A47	MEDDRA-PT E12 Death
A48	MEDDRA-PT-ID E12 10011906
A49	CUI E13 C1739145
A50	UMLS-Preferred-Name E13 Hepatitis B aggravated
A51	MEDDRA-PT E13 Hepatitis B
A52	MEDDRA-PT-ID E13 10019731
A53	LLT E13 Hepatitis B aggravated
A54	LLT-ID E13 10066627
A55	CUI E14 C0085605
A56	UMLS-Preferred-Name E14 Liver Failure
A57	MEDDRA-PT E14 Hepatic failure
A58	MEDDRA-PT-ID E14 10019663
A59	LLT E14 Hepatic decompensation
A60	LLT-ID E14 10076894
A61	CUI E15 C0085605
A62	UMLS-Preferred-Name E15 Liver Failure
A63	MEDDRA-PT E15 Hepatic failure
A64	MEDDRA-PT-ID E15 10019663
A65	LLT E15 Liver failure
A66	LLT-ID E15 10024678
A67	CUI E16 C1565489
A68	UMLS-Preferred-Name E16 Renal Insufficiency
A69	MEDDRA-PT E16 Renal impairment
A70	MEDDRA-PT-ID E16 10062237
A71	CUI E17 C0022660
A72	UMLS-Preferred-Name E17 Kidney Failure, Acute
A73	MEDDRA-PT E17 Acute kidney injury
A74	MEDDRA-PT-ID E17 10069339
A75	LLT E17 Acute renal failure
A76	LLT-ID E17 10001041
A77	CUI E18 C0015624
A78	UMLS-Preferred-Name E18 Fanconi Syndrome
A79	MEDDRA-PT E18 Fanconi syndrome
A80	MEDDRA-PT-ID E18 10016219
A81	flag E19 underspecified
A82	CUI E19 C0151747
A83	UMLS-Preferred-Name E19 Renal tubular disorder
A84	MEDDRA-PT E19 Renal tubular disorder
A85	MEDDRA-PT-ID E19 10038537
A86	LLT E19 Renal tubular dysfunction
A87	LLT-ID E19 10050335
A88	CUI E20 C0085682
A89	UMLS-Preferred-Name E20 Hypophosphatemia
A90	MEDDRA-PT E20 Hypophosphataemia
A91	MEDDRA-PT-ID E20 10021058
A92	LLT E20 Hypophosphatemia
A93	LLT-ID E20 10021059
A94	CUI E21 C1557806
A95	UMLS-Preferred-Name E21 Adverse Event Associated with the Kidney and Genitourinary System
A96	MEDDRA-PT E21 Renal impairment
A97	MEDDRA-PT-ID E21 10062237
A98	LLT E21 Renal function disorder
A99	LLT-ID E21 10038455
A100	CUI E22 C0015624
A101	UMLS-Preferred-Name E22 Fanconi Syndrome
A102	MEDDRA-PT E22 Renal tubular disorder
A103	MEDDRA-PT-ID E22 10038537
A104	LLT E22 Proximal renal tubular dysfunction
A105	LLT-ID E22 10037081
A106	CUI E23 C0015624
A107	UMLS-Preferred-Name E23 Fanconi Syndrome
A108	MEDDRA-PT E23 Renal tubular disorder
A109	MEDDRA-PT-ID E23 10038537
A110	LLT E23 Proximal renal tubular dysfunction
A111	LLT-ID E23 10037081
A112	CUI E30 C0700225
A113	UMLS-Preferred-Name E30 Serum creatinine raised
A114	MEDDRA-PT E30 Blood creatinine increased
A115	MEDDRA-PT-ID E30 10005483
A116	LLT E30 Serum creatinine increased
A117	LLT-ID E30 10040233
A118	CUI E32 C1262229
A119	UMLS-Preferred-Name E32 Creatinine clearance estimation decreased
A120	MEDDRA-PT E32 Creatinine renal clearance decreased
A121	MEDDRA-PT-ID E32 10011372
A122	LLT E32 Creatinine clearance estimation decreased
A123	LLT-ID E32 10061436
A124	CUI E34 C0877225
A125	UMLS-Preferred-Name E34 Bone density decreased
A126	MEDDRA-PT E34 Bone density decreased
A127	MEDDRA-PT-ID E34 10049470
A128	CUI E35 C0029442
A129	UMLS-Preferred-Name E35 Osteomalacia
A130	MEDDRA-PT E35 Osteomalacia
A131	MEDDRA-PT-ID E35 10031250
A132	CUI E36 C1839603
A133	UMLS-Preferred-Name E36 Proximal tubulopathy
A134	MEDDRA-PT E36 Renal tubular disorder
A135	MEDDRA-PT-ID E36 10038537
A136	LLT E36 Proximal renal tubular dysfunction
A137	LLT-ID E36 10037081
A138	CUI E37 C0151825
A139	UMLS-Preferred-Name E37 Bone pain
A140	MEDDRA-PT E37 Bone pain
A141	MEDDRA-PT-ID E37 10006002
A142	CUI E38 C0030196
A143	UMLS-Preferred-Name E38 Pain in limb
A144	MEDDRA-PT E38 Pain in extremity
A145	MEDDRA-PT-ID E38 10033425
A146	CUI E39 C0016658
A147	UMLS-Preferred-Name E39 Fracture
A148	MEDDRA-PT E39 Fracture
A149	MEDDRA-PT-ID E39 10017076
A150	CUI E41 C0003862
A151	UMLS-Preferred-Name E41 Arthralgia
A152	MEDDRA-PT E41 Arthralgia
A153	MEDDRA-PT-ID E41 10003239
A154	CUI E42 C0231528
A155	UMLS-Preferred-Name E42 Myalgia
A156	MEDDRA-PT E42 Myalgia
A157	MEDDRA-PT-ID E42 10028411
A158	LLT E42 Muscle pain
A159	LLT-ID E42 10028322
A160	CUI E43 C0151786
A161	UMLS-Preferred-Name E43 Muscle Weakness
A162	MEDDRA-PT E43 Muscular weakness
A163	MEDDRA-PT-ID E43 10028372
A164	LLT E43 Weakness muscle
A165	LLT-ID E43 10047867
A166	CUI E44 C1839603
A167	UMLS-Preferred-Name E44 Proximal tubulopathy
A168	MEDDRA-PT E44 Renal tubular disorder
A169	MEDDRA-PT-ID E44 10038537
A170	LLT E44 Proximal renal tubular dysfunction
A171	LLT-ID E44 10037081
A172	CUI E45 C0856151
A173	UMLS-Preferred-Name E45 Fat redistribution
A174	MEDDRA-PT E45 Fat redistribution
A175	MEDDRA-PT-ID E45 10048474
A176	CUI E46 C1096393
A177	UMLS-Preferred-Name E46 Body fat disorder
A178	MEDDRA-PT E46 Body fat disorder
A179	MEDDRA-PT-ID E46 10055164
A180	CUI E47 C0311277
A181	UMLS-Preferred-Name E47 Obesity, Abdominal
A182	MEDDRA-PT E47 Central obesity
A183	MEDDRA-PT-ID E47 10065941
A184	CUI E48 C0520573
A185	UMLS-Preferred-Name E48 Buffalo hump
A186	MEDDRA-PT E48 Lipohypertrophy
A187	MEDDRA-PT-ID E48 10062315
A188	LLT E48 Buffalo hump
A189	LLT-ID E48 10006539
A190	CUI E49 C0520573
A191	UMLS-Preferred-Name E49 Buffalo hump
A192	MEDDRA-PT E49 Lipohypertrophy
A193	MEDDRA-PT-ID E49 10062315
A194	LLT E49 Buffalo hump
A195	LLT-ID E49 10006539
A196	CUI E50 C0333650
A197	UMLS-Preferred-Name E50 Adipose Tissue Atrophy
A198	MEDDRA-PT E50 Lipoatrophy
A199	MEDDRA-PT-ID E50 10024604
A200	LLT E50 Fat atrophy NOS
A201	LLT-ID E50 10016242
A202	CUI E51 C1112303
A203	UMLS-Preferred-Name E51 Facial wasting
A204	MEDDRA-PT E51 Facial wasting
A205	MEDDRA-PT-ID E51 10056866
A206	CUI E52 C2225524
A207	UMLS-Preferred-Name E52 Macromastia
A208	MEDDRA-PT E52 Breast enlargement
A209	MEDDRA-PT-ID E52 10006242
A210	CUI E53 C0742929
A211	UMLS-Preferred-Name E53 CUSHINGOID APPEARANCE
A212	MEDDRA-PT E53 Cushingoid
A213	MEDDRA-PT-ID E53 10011655
A214	LLT E53 Cushingoid facies
A215	LLT-ID E53 10011656
A216	CUI E54 C1096197
A217	UMLS-Preferred-Name E54 Immune reconstitution syndrome
A218	MEDDRA-PT E54 Immune reconstitution inflammatory syndrome
A219	MEDDRA-PT-ID E54 10065042
A220	LLT E54 Immune reconstitution syndrome
A221	LLT-ID E54 10054014
A222	CUI E55 C0029118
A223	UMLS-Preferred-Name E55 Opportunistic Infections
A224	MEDDRA-PT E55 Opportunistic infection
A225	MEDDRA-PT-ID E55 10030901
A226	CUI E56 C1411980
A227	UMLS-Preferred-Name E56 Mycobacterium avium infection
A228	MEDDRA-PT E56 Mycobacterium avium complex infection
A229	MEDDRA-PT-ID E56 10058806
A230	LLT E56 Infection mycobacterium avium
A231	LLT-ID E56 10021840
A232	CUI E57 C0010823
A233	UMLS-Preferred-Name E57 Cytomegalovirus Infections
A234	MEDDRA-PT E57 Cytomegalovirus infection
A235	MEDDRA-PT-ID E57 10011831
A236	CUI E58 C1535939
A237	UMLS-Preferred-Name E58 Pneumocystis jiroveci pneumonia
A238	MEDDRA-PT E58 Pneumocystis jirovecii pneumonia
A239	MEDDRA-PT-ID E58 10073755
A240	CUI E59 C1535939
A241	UMLS-Preferred-Name E59 Pneumocystis jiroveci pneumonia
A242	MEDDRA-PT E59 Pneumocystis jirovecii pneumonia
A243	MEDDRA-PT-ID E59 10073755
A244	CUI E60 C0041296
A245	UMLS-Preferred-Name E60 Tuberculosis
A246	MEDDRA-PT E60 Tuberculosis
A247	MEDDRA-PT-ID E60 10044755
A248	CUI E61 C0004364
A249	UMLS-Preferred-Name E61 Autoimmune Diseases
A250	MEDDRA-PT E61 Autoimmune disorder
A251	MEDDRA-PT-ID E61 10061664
A252	CUI E62 C0018213
A253	UMLS-Preferred-Name E62 Graves Disease
A254	MEDDRA-PT E62 Basedow's disease
A255	MEDDRA-PT-ID E62 10004161
A256	LLT E62 Graves' disease
A257	LLT-ID E62 10018706
A258	CUI E63 C0085655
A259	UMLS-Preferred-Name E63 Polymyositis
A260	MEDDRA-PT E63 Polymyositis
A261	MEDDRA-PT-ID E63 10036102
A262	CUI E64 C0018378
A263	UMLS-Preferred-Name E64 Guillain-Barre Syndrome
A264	MEDDRA-PT E64 Guillain-Barre syndrome
A265	MEDDRA-PT-ID E64 10018767
A266	flag E25 unmapped
A267	CUI E26 C1262307
A268	UMLS-Preferred-Name E26 High turnover bone disease
A269	MEDDRA-PT E26 High turnover osteopathy
A270	MEDDRA-PT-ID E26 10062624
A271	LLT E26 High turnover bone disease
A272	LLT-ID E26 10062633
A273	CUI E28 C0877225
A274	UMLS-Preferred-Name E28 Bone density decreased
A275	MEDDRA-PT E28 Bone density decreased
A276	MEDDRA-PT-ID E28 10049470
A277	CUI E29 C1565489
A278	UMLS-Preferred-Name E29 Renal Insufficiency
A279	MEDDRA-PT E29 Renal impairment
A280	MEDDRA-PT-ID E29 10062237
A281	CUI E65 C0877225
A282	UMLS-Preferred-Name E65 Bone density decreased
A283	MEDDRA-PT E65 Bone density decreased
A284	MEDDRA-PT-ID E65 10049470
